How Equels was paid
$1.1M in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Other | Total |
|---|---|---|---|---|
| Thomas K EquelsCEO & President | $783,333 | $200,000 | $106,392 | $1,089,725 |
| Robert Dickey IVCFO | $49,549 | — | — | $49,549 |
| Peter RodinoCOO, General Counsel & Secretary | $408,333 | $50,000 | $63,016 | $521,349 |
What changed and why
- $1.1M$1,089,725 was CEO Thomas Equels’ 2024 total compensation, down from $1,431,301 in 2023.
- $200K$200,000 of Equels’ 2024 compensation was reported as stock awards.
- $250K$250,000 of stock was issued as payroll to certain named executives during 2024.
- 2024 bonus compensation was voluntarily waived by executive officers to support cash conservation.
- $63,016$63,016 was Peter Rodino’s 2024 all-other compensation, including $20,700 in 401(k) matching funds.
- Options granted in 2024 were waived.
Other AIM ImmunoTech proxy statements
- 2026 proxy statement
Thomas K Equels paid $822,983 (-24% on the year).
Filed Sep 30, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.